Drug Interactions Between Nortriptyline and Amitriptyline

Introduction to Tricyclic Antidepressants

Nortriptyline is the active metabolite of amitriptyline, making their combination pharmacologically redundant 1
The American Academy of Child and Adolescent Psychiatry recommends avoiding the combination of two tricyclic antidepressants due to increased risk of serotonin syndrome and cardiac toxicity 2

Therapeutic drug monitoring data shows that patients on amitriptyline achieve mean amitriptyline levels of 100±41 ng/mL plus nortriptyline levels of 71±38 ng/mL from metabolism alone, indicating that combining them provides no additional therapeutic mechanism 1
The Mayo Clinic recommends continuing amitriptyline alone at doses of 75-150 mg/day for neuropathic pain or depression, with monitoring for therapeutic response using both parent compound and metabolite plasma levels 3

Both drugs cause identical anticholinergic side effects, including dry mouth, orthostatic hypotension, constipation, urinary retention, blurred vision, and confusion, with the American Gastroenterological Association noting the risks of these effects 3, 4
Cardiac toxicity is a major concern as both TCAs prolong QTc interval and can cause arrhythmias, with additive effects when combined, according to the Journal of the American Academy of Child and Adolescent Psychiatry 2, 4

If a patient is currently on amitriptyline, the American Academy of Child and Adolescent Psychiatry recommends continuing amitriptyline alone at doses of 75-150 mg/day, with monitoring for therapeutic response using both parent compound and metabolite plasma levels 3, 4
If switching from amitriptyline to nortriptyline, the Diabetes/Metabolism Research and Reviews journal suggests that nortriptyline is preferred over amitriptyline due to its superior side effect profile while maintaining equivalent efficacy 5

Both drugs are contraindicated in patients with cardiovascular disease, including recent MI, arrhythmias, or heart block, as stated by the Diabetes/Metabolism Research and Reviews journal 5
The Journal of the American Academy of Child and Adolescent Psychiatry recommends avoiding TCAs in patients with prolonged QTc syndrome 2
The Mayo Clinic Proceedings journal suggests using nortriptyline preferentially in elderly patients as it has fewer anticholinergic effects than amitriptyline 3

The combination of TCAs with other medications, such as fluvoxamine, divalproex sodium, and terbinafine, requires careful monitoring due to potential drug interactions, although specific details on these interactions are not provided in the cited references 1, 2

The American Academy of Sleep Medicine notes that amitriptyline is specifically listed among sedating antidepressants, while nortriptyline is not highlighted for this purpose 6, 7
For neuropathic pain management, nortriptyline is preferred over amitriptyline due to its superior side effect profile while maintaining similar efficacy 8
The American Family Physician guidelines note that nortriptyline "tends to be more sedating" than desipramine but is still less sedating than amitriptyline 9, 10
For patients with neuropathic pain, starting with nortriptyline is recommended due to its better side effect profile with similar efficacy 8, 11

Nortriptyline is typically started at 10-25mg at bedtime and can be increased to 25-100mg as tolerated 8, 12
For pain management, nortriptyline is started at lower doses (10-25mg) and gradually increased every 3-7 days to minimize side effects 8, 13

Elderly patients are more sensitive to the sedative effects of both drugs and should generally start at lower doses 6, 12
Patients with cardiac conditions should use either drug with caution, as both can affect cardiac conduction 11

The maximum recommended dose of amitriptyline for neuropathic pain management and depression treatment is 150 mg per day, with a starting dose of 10-25 mg at bedtime and gradual increase by 25 mg every 3-7 days as tolerated, according to the American College of Cardiology and Mayo Clinic Proceedings 14
For neuropathic pain management, the maximum dosage is 150 mg/day, as recommended by the American College of Cardiology and Mayo Clinic Proceedings 14, 15
Blood concentration monitoring is recommended when approaching maximum doses, and if blood concentration of active medication and its metabolite is below a certain threshold, titration can continue with caution, as suggested by Mayo Clinic Proceedings 14
Amitriptyline is often effective for pain management at doses lower than those required for depression treatment, as noted by the National Comprehensive Cancer Network 16
Common adverse effects of amitriptyline include sedation, dry mouth, orthostatic hypotension, confusion, weight gain, urinary retention, constipation, and blurred vision, according to the American College of Cardiology 15

Amitriptyline causes significantly more anticholinergic side effects, including dry mouth, constipation, urinary retention, blurred vision, and confusion, compared to nortriptyline, which has fewer anticholinergic effects, making it better tolerated, especially in elderly patients 17

Both drugs are equally effective for treating depression, with amitriptyline having been a reference compound for depression treatment for many years, according to the American Academy of Neurology 18

Amitriptyline has consistent evidence for migraine prevention at doses of 30-150 mg/day, and is superior for patients with mixed migraine and tension-type headache, as recommended by the American Headache Society 19

Nortriptyline is preferred over amitriptyline for neuropathic pain management due to its equivalent efficacy with a better tolerability profile, as suggested by the Clinical Gastroenterology and Hepatology guidelines 17

For chemotherapy-induced peripheral neuropathy (CIPN), a small randomized trial (n=51) of nortriptyline targeting 100 mg/day showed no significant benefit, suggesting it may be less effective for this specific neuropathic pain subtype 20

A large retrospective study demonstrated an increased risk of sudden cardiac death with tricyclic antidepressant doses exceeding 100 mg/day, particularly in patients with cardiovascular disease or elderly patients, highlighting the importance of careful dosing and monitoring 21
The American Heart Association recommends obtaining an electrocardiogram before initiating therapy, especially if doses will exceed 100 mg/day, to minimize the risk of cardiac complications 21
Patients with a history of cardiovascular disease require extreme caution when using nortriptyline, and alternative treatments should be considered 21

Elderly patients require substantially lower doses of nortriptyline, starting at 10 mg/day and titrating slowly, due to higher plasma concentrations of the active metabolite 10-hydroxynortriptyline 21

For painful diabetic peripheral neuropathy, the dosing strategy differs from depression treatment, starting at 10 mg/day and titrating gradually as needed up to 75 mg/day 21